CAMBIO DE DISCURSO : LA SEGUNDA LINEA SMALL CELL LUNG CANCER EXTENSIVE-STAGE TRAS EL FIASCO DE LA FASE III LAGOON YA MEJOR NI NOMBRARLA ... CAMBIAMOS DISCURSO A MANTENIMIENTO EN PRIMERA LINEA Y PASAMOS DEL VIAL DE 4 Mg AI VIAL DE 2 Mg . ////. ESPERAMOS DECISIÓN DE JAZZPHARMA O BIEN LA DECISIÓN DE LA FDA TEMA SEGUNDA LÍNEA EEUU .////. 2 DE OCTUBRE DE 2028 ... ES LA FECHA MÁS TEPMPRANA PARA LA POSIBLE ENTRADA DE GENÉRICOS .
15 junio 2007
Patente EEUU , Yondelis consigue Reforzar los efectos citotóxicos del Platinum .
Combined use of Yondelis and platinum antineoplastic compounds .
Publication number: US2007128201
Publication date: 2007-06-07
Inventor: D INCALCI MAURIZIO (IT); GIANNI LUCA (IT); GIAVAZZI RAFFAELLA (IT); MARTIN MARGARITA G (ES); JUDSON IAN (GB); DONAQUE JOSE M J (ES); SESSA CRISTIANA (CH)
Applicant: PHARMA MAR S A U (ES)
Classification: - international: A61K39/395; A61K31/282; A61K31/495; A61K31/555; A61K33/24; A61P35/00; A61K39/395; A61K31/28; A61K31/495; A61K31/555; A61K33/24; A61P35/00; - European: A61K31/282; A61K31/495; A61K31/555; A61K33/24
Application number: US20040558133 20040601
Priority number(s): GB20030012407 20030529; WO2004GB02319 20040601
Abstract of US2007128201 Yondelis can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.
Publication number: US2007128201
Publication date: 2007-06-07
Inventor: D INCALCI MAURIZIO (IT); GIANNI LUCA (IT); GIAVAZZI RAFFAELLA (IT); MARTIN MARGARITA G (ES); JUDSON IAN (GB); DONAQUE JOSE M J (ES); SESSA CRISTIANA (CH)
Applicant: PHARMA MAR S A U (ES)
Classification: - international: A61K39/395; A61K31/282; A61K31/495; A61K31/555; A61K33/24; A61P35/00; A61K39/395; A61K31/28; A61K31/495; A61K31/555; A61K33/24; A61P35/00; - European: A61K31/282; A61K31/495; A61K31/555; A61K33/24
Application number: US20040558133 20040601
Priority number(s): GB20030012407 20030529; WO2004GB02319 20040601
Abstract of US2007128201 Yondelis can be used to mitigate resistance to and potentiate the cytotoxic effects of a platinum coordination complex anti-neoplastic agent in a human cancer patient.